This year has already seen several high profile initial public offerings and the results have been mixed. Ride-sharing giants Uber (UBER) and Lyft (LYFT) have been disappointing so far with both trading below the IPO price. Uber has[…]
Read moreCategory: Investment News
Stock Buyback Frenzy: Was This An Effective Use of Capital?
A record number of firms have been repurchasing their own shares off the public market in an attempt to utilize cash effectively. Companies bought back over $1 trillion of their own stock in 2018 with the new tax[…]
Read more
Stock Buyback Frenzy: May Be Adverse To Long-Term Objectives
Stock buybacks have been prolific in the past 15 months. This aggressive repurchase strategy might not be as beneficial as the market wants us to believe. Analysts at Ned Davis Research estimates that the S&P 500 would be[…]
Read more
Stock Buyback Frenzy: How This Will Effect You
Corporate cash reserves have been swelling, as firms repatriated $665 billion back into the US in 2018 and corporate cash flows are hitting all-time highs, partly due to the reduced corporate tax rate. Businesses have reviewed their possible[…]
Read more
Fundamental Market Overview: Equities, Oil Prices, Interest Rates, Gold Prices and More
Equity Market The S&P 500 just bounced off another all-time high today as stronger than expected earnings continue to boost the market. The S&P 500 has grown 17.5% since the beginning of the year, continuing its momentum from[…]
Read moreA Big Deal Reignites Cannabis Stocks
Late last Thursday, during the final trading session of a holiday-shortened week, Canadian Cannabis company Canopy Growth Corp (CGC) announced that it had reached an agreement to purchase 100% of US cannabis investment company Acreage Holdings in a[…]
Read moreNew Age Beverages Corporation (NBEV) Gets a Hold Rating from Maxim Group
In a report released today, Anthony Vendetti from Maxim Group maintained a Hold rating on New Age Beverages Corporation (NBEV). The company’s shares opened today at $5.44. Vendetti said: “NBEV reported 4Q18 revenue above our estimate, we believe[…]
Read moreH.C. Wainwright Thinks Madrigal Pharmaceuticals Inc’s Stock is Going to Recover
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Madrigal Pharmaceuticals Inc (MDGL) today and set a price target of $228. The company’s shares opened today at $126.86, close to its 52-week low of $91.56. Arce noted:[…]
Read more
Oppenheimer Maintains a Hold Rating on RH (RH)
In a report released today, Brian Nagel from Oppenheimer maintained a Hold rating on RH (RH). The company’s shares opened today at $112.77. Nagel wrote: “Yesterday (Mar. 28th) after the market close, Perform-rated RH (RH) reported fiscal Q4:18[…]
Read moreCelyad (CYAD) Gets a Buy Rating from H.C. Wainwright
H.C. Wainwright analyst Edward White maintained a Buy rating on Celyad (CYAD) today and set a price target of $52. The company’s shares opened today at $21.09. White wrote: “We base our $52 price target on probability-adjusted revenue[…]
Read more
